PDA

View Full Version : [RSS Channel 1] Crohn's News



Страницы : [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36

  1. New Phase III Data Shows Abbott's HUMIRA(R) (Adalimumab) Induced Clinical Remission I
  2. UCB Provides Update On CIMZIA(TM) For Crohn's Disease And Rheumatoid Arthritis In The
  3. Molecular Basis Of Inflammatory Bowel Disease Identified By Researchers
  4. HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment Of Crohn's Disease
  5. Decades-Long Study Will Help Improve Surgery For Crohn's Disease
  6. AmeriHealth Expands Disease Management Program To Benefit Members With Crohn's Diseas
  7. Pilot Study Shows Withdrawal Drug Offers Symptom Relief To Crohn's Sufferers
  8. MedInsight(SM) Announces Clinical Trial Results Of Low-dose Naltrexone; Potential Bre
  9. Spot The Difference: Proteasome Composition Differs In Crohn Disease And Ulcerative C
  10. The Majority Of Ulcerative Colitis Patients Are Not Compliant With Medications, CCFA
  11. Ocera Therapeutics Initiates A Phase 2 Trial For Active Pouchitis
  12. Unacceptable Variation In Care For People With Inflammatory Bowel Disease - Royal Col
  13. European Union CHMP Recommends Approval Of First And Only Biologic Treatment For Pedi
  14. Scientists Find Major Susceptibility Gene For Crohn's Disease
  15. Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review For The Treatment Of Mode
  16. Crohn's Disease Gene Identified
  17. Researchers On Multicenter Team Linking Gene Mutation To Crohn's Disease
  18. Crohn's And Colitis Awareness Month 2006 - Message From Tony Clement, Minister Of Hea
  19. Abbott's Humira® (Adalimumab) Granted FDA Priority Review For The Treatment Of Modera
  20. New Therapy For Patients With Crohn's Disease Identified By Researchers